Cyndeo Wealth Partners LLC Buys New Position in HCA Healthcare, Inc. $HCA

Key Points

• Cyndeo Wealth Partners LLC recently acquired a new stake in HCA Healthcare, purchasing 24,475 shares valued at approximately $9.4 million.
• HCA Healthcare reported a quarterly earnings per share (EPS) of $6.84, exceeding analysts' estimates by $0.64, alongside a revenue of $18.61 billion.
• The company announced a quarterly dividend of $0.72 per share, with a dividend yield of 0.7% and a payout ratio of 12.11%.

Cyndeo Wealth Partners LLC bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 24,475 shares of the company's stock, valued at approximately $9,376,000.

Other large investors have also bought and sold shares of the company. Cheviot Value Management LLC bought a new position in HCA Healthcare during the first quarter valued at about $26,000. Saudi Central Bank acquired a new position in shares of HCA Healthcare in the 1st quarter valued at $26,000. WPG Advisers LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at $27,000. Ameriflex Group Inc. acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $27,000. Finally, Chung Wu Investment Group LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $27,000. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

HCA opened at $418.35 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $439.01. The business has a 50-day moving average of $403.96 and a 200-day moving average of $375.04. The company has a market capitalization of $97.89 billion, a PE ratio of 17.59, a price-to-earnings-growth ratio of 1.34 and a beta of 1.40.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same period last year, the business earned $5.50 EPS. The business's quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were issued a dividend of $0.72 per share. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is currently 12.11%.

Analysts Set New Price Targets

A number of research firms recently weighed in on HCA. Weiss Ratings reiterated a "buy (b-)" rating on shares of HCA Healthcare in a research report on Wednesday. Robert W. Baird increased their price objective on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. Cantor Fitzgerald reissued an "overweight" rating and issued a $444.00 price objective on shares of HCA Healthcare in a research note on Tuesday. Wells Fargo & Company increased their price objective on HCA Healthcare from $375.00 to $412.00 and gave the stock an "equal weight" rating in a research note on Tuesday. Finally, Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $422.31.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares of the company's stock, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.30% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.